Patents by Inventor Deepthi Gadde

Deepthi Gadde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hyperimmunized egg product for treatment of necrotic enteritis in poultry
    Patent number: 11230590
    Abstract: In one aspect, the present invention is directed to a method for preventing or treating necrotic enteritis by administering a hyperimmunized egg product obtained from an egg-producing animal to an avian. The hyperimmunized egg product may contain an antibody specific to an antigen selected from the group consisting of Clostridium perfringens ?-toxin, Clostridium perfringens elongation factor Tu (EF-Tu), Clostridium perfringens necrotic enteritis B-like (NetB) toxin, Clostridium perfringens Pyruvate: Ferredoxin oxidoreductase (PFO), and Eimeria tenella elongation factor 1-alpha.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: January 25, 2022
    Assignees: Arkion Life Sciences, LLC, United States of America, as Represented by the Secretary of Agriculture
    Inventors: Hyun S. Lillehoj, Earnest W. Porta, Samuel V. Walker, Leslie A. Confer, Ujvala Deepthi Gadde, Cyril Gay
  • HYPERIMMUNIZED EGG PRODUCT FOR TREATMENT OF NECROTIC ENTERITIS IN POULTRY
    Publication number: 20200002404
    Abstract: In one aspect, the present invention is directed to a method for preventing or treating necrotic enteritis by administering a hyperimmunized egg product obtained from an egg-producing animal to an avian. The hyperimmunized egg product may contain an antibody specific to an antigen selected from the group consisting of Clostridium perfringens ?-toxin, Clostridium perfringens elongation factor Tu (EF-Tu), Clostridium perfringens necrotic enteritis B-like (NetB) toxin, Clostridium perfringens Pyruvate: Ferredoxin oxidoreductase (PFO), and Eimeria tenella elongation factor 1-alpha.
    Type: Application
    Filed: September 18, 2019
    Publication date: January 2, 2020
    Applicants: The United States of America, as Represented by the Secretary of Agriculture, Arkion Life Sciences, LLC
    Inventors: Hyun S. Lillehoj, Earnest W. Porta, Samuel V. Walker, Leslie A. Confer, Ujvala Deepthi Gadde, Cyril Gay
  • Hyperimmunized egg product for treatment of necrotic enteritis in poultry
    Patent number: 10450364
    Abstract: In one aspect, the present invention is directed to a method for preventing or treating necrotic enteritis by administering a hyperimmunized egg product obtained from an egg-producing animal to an avian. The hyperimmunized egg product may contain an antibody specific to an antigen selected from the group consisting of Clostridium perfringens ?-toxin, Clostridium perfringens elongation factor Tu (EF-Tu), Clostridium perfringens necrotic enteritis B-like (NetB) toxin, Clostridium perfringens Pyruvate: Ferredoxin oxidoreductase (PFO), and Eimeria tenella elongation factor 1-alpha.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: October 22, 2019
    Assignees: Arkion Life Sciences, LLC, United Sates of America, as Represented by the Secretary of Agriculture
    Inventors: Hyun S. Lillehoj, Earnest W. Porta, Samuel V. Walker, Leslie A. Confer, Ujvala Deepthi Gadde, Cyril Gay
  • HYPERIMMUNIZED EGG PRODUCT FOR TREATMENT OF NECROTIC ENTERITIS IN POULTRY
    Publication number: 20180230199
    Abstract: In one aspect, the present invention is directed to a method for preventing or treating necrotic enteritis by administering a hyperimmunized egg product obtained from an egg-producing animal to an avian. The hyperimmunized egg product may contain an antibody specific to an antigen selected from the group consisting of Clostridium perfringens ?-toxin, Clostridium perfringens elongation factor Tu (EF-Tu), Clostridium perfringens necrotic enteritis B-like (NetB) toxin, Clostridium perfringens Pyruvate: Ferredoxin oxidoreductase (PFO), and Eimeria tenella elongation factor 1-alpha.
    Type: Application
    Filed: February 13, 2018
    Publication date: August 16, 2018
    Applicants: The United States of America, as represented by the Secretary of Agriculture, Arkion Life Sciences, LLC
    Inventors: Hyun S. Lillehoh, Earnest W. Porta, Samuel V. Walker, Leslie A. Confer, Ujvala Deepthi Gadde, Cyril Gay
  • LANGUAGE INDEPENDENT CUSTOMER COMMUNICATIONS
    Publication number: 20160062987
    Abstract: A first user establishes a communication session with a second user. During the communication session the first user communicates and receives communication from the second user in a first human language while the second user communicates and receives communication from the first user in a second communication language. The first and second human communication languages are different from one another. In an embodiment, at least one human communication language is sign language. In an embodiment, at least one human communication language is communicated via animation.
    Type: Application
    Filed: August 26, 2014
    Publication date: March 3, 2016
    Inventors: Raja Shekhar Yapamanu, Uma Varakumari Gadasala, Marreddy Thumma, Mandapati Venkata Pradeep, Deepthi Gadde, Ian Maxwell Joy, Gordon Patton